The Unites States' general anesthesia drugs market is expected to reach approximately $2 billion by 2020, according to a MarketsandMarkets report.
Here are six important trends:
1. The market is expected to grow at a compound annual growth rate of 3.8 percent from 2015 to 2020.
2. The market was valued at $1.6 billion in 2015.
3. Factors such as rapid rise in aging population; rising prevalence of cardiovascular and respiratory system-related diseases; and rising number of emergency surgeries are driving the growth of the market.
4. However, side effects associated with ketamine usage, regulatory issues and lower compliance rates in comparison with other anesthetic drugs are likely to impede the market's growth.
5. The intravenous segment of the market is expected to account for the largest share in 2015.
6. Major players in the market include AstraZeneca, Baxter International, Hospira and Par Pharmaceutical Companies.